Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients with Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry. J of Skin [Internet]. 2025 Nov. 10 [cited 2026 Apr. 17];9(6):s632. Available from: https://skin.dermsquared.com/skin/article/view/3777